LEGN · NASDAQ · Biotechnology

Legend Biotech (ADR) (LEGN)

Commercializes CARVYKTI while developing next-generation CAR-T therapies.

$18.63
After hours−0.01 (−0.05%)
At close$18.64(+0.59%)